Researchers have developed a database of all ABCB11 mutations known to cause progressive familial intrahepatic cholestasis type 2 (PFIC2)…
Articles by Margarida Maia, PhD
A targeted treatment called transarterial chemoembolization (TACE) successfully helped control hepatocellular carcinoma (HCC), the most common type of liver cancer,…
AusperBio raised $50 million to advance the development of chronic hepatitis B treatment AHB-137. The company said the funding…
The U.S. Food and Drug Administration (FDA) has accepted for review GSK’s application seeking the approval of its oral treatment…
Hepatitis Awareness Month is held every May to raise awareness about viral hepatitis, an inflammation of the liver caused…
Exposure to high levels of fine particulate matter, or PM2.5, the most commonly studied air pollutant, and reduced time in…
A study of three children with progressive familial intrahepatic cholestasis type 3 (PFIC3) in China revealed that different disease-causing…
Measuring the blood levels of bile acids, the main component of the digestive fluid bile, can help predict key clinical…
Among second-line treatments for primary biliary cholangitis (PBC), Iqirvo (elafibranor) may work better than Livdelzi (seladelpar) at reducing markers…
A young woman in the U.S. who experienced recurrent cholestasis was later found, with the help of genetic testing,…